Global Peptide Conjugates Service Market Research Report 2024

Publication ID:

PB510246672

Publication Date:

October 16, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Peptide Conjugates Service generally refer to professional services provided for the fields of biomedicine, pharmaceuticals or scientific research, involving the combination of peptides with oligonucleotides, carrier proteins, DNA, RNA and small molecules, and are widely used in biological research, clinical medicine and drug development.
The global Peptide Conjugates Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Peptide Conjugates Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide Conjugates Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Peptide Conjugates Service in Vaccine Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Peptide Conjugates Service include Almac Group, Bio-Synthesis, Creative Peptides, ProtaGene GmbH, WuXi TIDES, Medtide Inc, Ajinomoto, PHARMARON, SBS Genetech, Creative Enzymes, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide Conjugates Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Conjugates Service.
The Peptide Conjugates Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Conjugates Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Conjugates Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Almac Group
Bio-Synthesis
Creative Peptides
ProtaGene GmbH
WuXi TIDES
Medtide Inc
Ajinomoto
PHARMARON
SBS Genetech
Creative Enzymes
AnaSpec
BOCSCI Inc
JPT Peptide Technologies
Kaneka Eurogentec SA
QYAOBIO
Segment by Type
Peptide Oligonucleotide Conjugates
Peptide Carrier Protein Conjugates
Peptide Small Molecule Conjugates
Other
Segment by Application
Vaccine Development
Drug Delivery
Biomarkers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Conjugates Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Conjugates Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Peptide Oligonucleotide Conjugates
1.2.3 Peptide Carrier Protein Conjugates
1.2.4 Peptide Small Molecule Conjugates
1.2.5 Other
1.3 Market by Application
1.3.1 Global Peptide Conjugates Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaccine Development
1.3.3 Drug Delivery
1.3.4 Biomarkers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Conjugates Service Market Perspective (2019-2030)
2.2 Global Peptide Conjugates Service Growth Trends by Region
2.2.1 Global Peptide Conjugates Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Conjugates Service Historic Market Size by Region (2019-2024)
2.2.3 Peptide Conjugates Service Forecasted Market Size by Region (2025-2030)
2.3 Peptide Conjugates Service Market Dynamics
2.3.1 Peptide Conjugates Service Industry Trends
2.3.2 Peptide Conjugates Service Market Drivers
2.3.3 Peptide Conjugates Service Market Challenges
2.3.4 Peptide Conjugates Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Conjugates Service Players by Revenue
3.1.1 Global Top Peptide Conjugates Service Players by Revenue (2019-2024)
3.1.2 Global Peptide Conjugates Service Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Conjugates Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Conjugates Service Revenue
3.4 Global Peptide Conjugates Service Market Concentration Ratio
3.4.1 Global Peptide Conjugates Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Conjugates Service Revenue in 2023
3.5 Global Key Players of Peptide Conjugates Service Head office and Area Served
3.6 Global Key Players of Peptide Conjugates Service, Product and Application
3.7 Global Key Players of Peptide Conjugates Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Conjugates Service Breakdown Data by Type
4.1 Global Peptide Conjugates Service Historic Market Size by Type (2019-2024)
4.2 Global Peptide Conjugates Service Forecasted Market Size by Type (2025-2030)
5 Peptide Conjugates Service Breakdown Data by Application
5.1 Global Peptide Conjugates Service Historic Market Size by Application (2019-2024)
5.2 Global Peptide Conjugates Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Conjugates Service Market Size (2019-2030)
6.2 North America Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Conjugates Service Market Size by Country (2019-2024)
6.4 North America Peptide Conjugates Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Conjugates Service Market Size (2019-2030)
7.2 Europe Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Conjugates Service Market Size by Country (2019-2024)
7.4 Europe Peptide Conjugates Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Conjugates Service Market Size (2019-2030)
8.2 Asia-Pacific Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Conjugates Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Conjugates Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Conjugates Service Market Size (2019-2030)
9.2 Latin America Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Conjugates Service Market Size by Country (2019-2024)
9.4 Latin America Peptide Conjugates Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Conjugates Service Market Size (2019-2030)
10.2 Middle East & Africa Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Conjugates Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Conjugates Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Almac Group
11.1.1 Almac Group Company Details
11.1.2 Almac Group Business Overview
11.1.3 Almac Group Peptide Conjugates Service Introduction
11.1.4 Almac Group Revenue in Peptide Conjugates Service Business (2019-2024)
11.1.5 Almac Group Recent Development
11.2 Bio-Synthesis
11.2.1 Bio-Synthesis Company Details
11.2.2 Bio-Synthesis Business Overview
11.2.3 Bio-Synthesis Peptide Conjugates Service Introduction
11.2.4 Bio-Synthesis Revenue in Peptide Conjugates Service Business (2019-2024)
11.2.5 Bio-Synthesis Recent Development
11.3 Creative Peptides
11.3.1 Creative Peptides Company Details
11.3.2 Creative Peptides Business Overview
11.3.3 Creative Peptides Peptide Conjugates Service Introduction
11.3.4 Creative Peptides Revenue in Peptide Conjugates Service Business (2019-2024)
11.3.5 Creative Peptides Recent Development
11.4 ProtaGene GmbH
11.4.1 ProtaGene GmbH Company Details
11.4.2 ProtaGene GmbH Business Overview
11.4.3 ProtaGene GmbH Peptide Conjugates Service Introduction
11.4.4 ProtaGene GmbH Revenue in Peptide Conjugates Service Business (2019-2024)
11.4.5 ProtaGene GmbH Recent Development
11.5 WuXi TIDES
11.5.1 WuXi TIDES Company Details
11.5.2 WuXi TIDES Business Overview
11.5.3 WuXi TIDES Peptide Conjugates Service Introduction
11.5.4 WuXi TIDES Revenue in Peptide Conjugates Service Business (2019-2024)
11.5.5 WuXi TIDES Recent Development
11.6 Medtide Inc
11.6.1 Medtide Inc Company Details
11.6.2 Medtide Inc Business Overview
11.6.3 Medtide Inc Peptide Conjugates Service Introduction
11.6.4 Medtide Inc Revenue in Peptide Conjugates Service Business (2019-2024)
11.6.5 Medtide Inc Recent Development
11.7 Ajinomoto
11.7.1 Ajinomoto Company Details
11.7.2 Ajinomoto Business Overview
11.7.3 Ajinomoto Peptide Conjugates Service Introduction
11.7.4 Ajinomoto Revenue in Peptide Conjugates Service Business (2019-2024)
11.7.5 Ajinomoto Recent Development
11.8 PHARMARON
11.8.1 PHARMARON Company Details
11.8.2 PHARMARON Business Overview
11.8.3 PHARMARON Peptide Conjugates Service Introduction
11.8.4 PHARMARON Revenue in Peptide Conjugates Service Business (2019-2024)
11.8.5 PHARMARON Recent Development
11.9 SBS Genetech
11.9.1 SBS Genetech Company Details
11.9.2 SBS Genetech Business Overview
11.9.3 SBS Genetech Peptide Conjugates Service Introduction
11.9.4 SBS Genetech Revenue in Peptide Conjugates Service Business (2019-2024)
11.9.5 SBS Genetech Recent Development
11.10 Creative Enzymes
11.10.1 Creative Enzymes Company Details
11.10.2 Creative Enzymes Business Overview
11.10.3 Creative Enzymes Peptide Conjugates Service Introduction
11.10.4 Creative Enzymes Revenue in Peptide Conjugates Service Business (2019-2024)
11.10.5 Creative Enzymes Recent Development
11.11 AnaSpec
11.11.1 AnaSpec Company Details
11.11.2 AnaSpec Business Overview
11.11.3 AnaSpec Peptide Conjugates Service Introduction
11.11.4 AnaSpec Revenue in Peptide Conjugates Service Business (2019-2024)
11.11.5 AnaSpec Recent Development
11.12 BOCSCI Inc
11.12.1 BOCSCI Inc Company Details
11.12.2 BOCSCI Inc Business Overview
11.12.3 BOCSCI Inc Peptide Conjugates Service Introduction
11.12.4 BOCSCI Inc Revenue in Peptide Conjugates Service Business (2019-2024)
11.12.5 BOCSCI Inc Recent Development
11.13 JPT Peptide Technologies
11.13.1 JPT Peptide Technologies Company Details
11.13.2 JPT Peptide Technologies Business Overview
11.13.3 JPT Peptide Technologies Peptide Conjugates Service Introduction
11.13.4 JPT Peptide Technologies Revenue in Peptide Conjugates Service Business (2019-2024)
11.13.5 JPT Peptide Technologies Recent Development
11.14 Kaneka Eurogentec SA
11.14.1 Kaneka Eurogentec SA Company Details
11.14.2 Kaneka Eurogentec SA Business Overview
11.14.3 Kaneka Eurogentec SA Peptide Conjugates Service Introduction
11.14.4 Kaneka Eurogentec SA Revenue in Peptide Conjugates Service Business (2019-2024)
11.14.5 Kaneka Eurogentec SA Recent Development
11.15 QYAOBIO
11.15.1 QYAOBIO Company Details
11.15.2 QYAOBIO Business Overview
11.15.3 QYAOBIO Peptide Conjugates Service Introduction
11.15.4 QYAOBIO Revenue in Peptide Conjugates Service Business (2019-2024)
11.15.5 QYAOBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Almac Group
Bio-Synthesis
Creative Peptides
ProtaGene GmbH
WuXi TIDES
Medtide Inc
Ajinomoto
PHARMARON
SBS Genetech
Creative Enzymes
AnaSpec
BOCSCI Inc
JPT Peptide Technologies
Kaneka Eurogentec SA
QYAOBIO

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂